Find a registrant or pharmacy

Find a registrant Find a pharmacy

Search the website

Help me with...

Which patients are eligible for NAS stock? New direction

October 27, 2009

Many pharmacists have phoned ACP to ask how to assess if a prescription should be filled from the NAS stock or their own retail stock. We referred callers to the Alberta Health and Wellness (AHW) decision-making algorithm. On Oct. 27, AHW provided ACP with the following clarification:

“All prescriptions for antivirals should be filled out of the NAS stock unless the prescriber specifically and clearly indicates otherwise on the script.”

We know keeping up with the flood of ever-changing information is tricky. To help, we’ve created one “go to” spot on our website for all H1N1 information. We’re also maintaining an FAQ document to supplement the information from other sources.

Please review the information on the ACP website to make sure you are working with the most up-to-date information.

Here are answers to two questions we have frequently been asked:

How do I order more NAS antivirals?

Alberta Health Services (AHS) has contracted with McKesson Canada to distribute NAS antivirals. McKesson has developed ordering processes specifically for these products. Contact your local McKesson Canada distributor or go to their website for more information.

The order numbers for the NAS Tamiflu (which are different from ‘private’ stock order numbers) are:

Tamiflu 30mg – 480434

Tamiflu 45mg – 482158

Tamiflu 75mg – 487462

Where can I go for more information?

ACP website: H1N1 – pharmacist information (under the Bulletin Board section).

For billing, claims or payment information: Alberta Blue Cross pharmacy lines at Edmonton 780-498-8370; Calgary 403-294-4041; toll-free 1-800-361-9632.

For ordering or shipping of NAS: McKesson. Use your usual contact mechanisms

For information on AHS Influenza Clinics: Health Link: Calgary 403- 943-5465, Edmonton 780- 408-5465, Toll-Free 1-866-408-5465, E-mail

Public Health clinic dates and locations

Originally published in the October 27, 2009, issue of The Link